Validating the New Remote Hypnotic Induction Profile (rHIP)

October 30, 2019 updated by: Jessie Kittle, Stanford University

A Randomized Trial Validating the New Remote Hypnotic Induction Profile (rHIP) Against the Existing Hypnotic Induction Profile (HIP)

The purpose of the study is to determine if hypnotizability can be reliably tested over the phone, without having to see or touch a patient. The scores from a new test for hypnotizability by phone will be compared to the scores from a standard in-person test, to make sure the results are similar.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • California
      • Palo Alto, California, United States, 94305
        • Stanford University/Stanford Healthcare

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • At least 18 years old.
  • Able to schedule a 15 minute in-person and phone appointment within a week of each other, during the study period.

Exclusion Criteria:

  • Severe psychiatric or structural brain disease (ie. psychosis, stroke with functional impairment, dementia)
  • Has had prior hypnotizability testing using the HIP or enrolled in another hypnosis-related trial.
  • hearing impairment that would preclude phone interviewing
  • non-English speakers

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: HIP First
Participants randomized to perform the in-person hypnotizability test first. This will be followed within 1 week with the by-phone rHIP test performed by a second, randomly-assigned investigator.
Other: Hypnotizability testing
Hypnotizability testing in-person vs. by phone. All participants will complete both conditions.
Active Comparator: rHIP First
Participants randomized to perform the by-phone hypnotizability test first. This will be followed within 1 week with the in-peron HIP test performed by a second, randomly-assigned investigator.
Other: Hypnotizability testing
Hypnotizability testing in-person vs. by phone. All participants will complete both conditions.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Reliability of HIP and rHIP test scores
Time Frame: Through study completion, approximately 2 months.
Calculate the correlation between the HIP and rHIP
Through study completion, approximately 2 months.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Hypnotizability and DES
Time Frame: Administered upon enrollment, prior to first hypnotizability test
Investigate any correlation between hypnotizability scores and the Dissociative Experiences Scale
Administered upon enrollment, prior to first hypnotizability test
Hypnotizability and Tellegen
Time Frame: Administered upon enrollment, prior to first hypnotizability test
Investigate any correlation between hypnotizability scores and the Tellegen Absorption Scale
Administered upon enrollment, prior to first hypnotizability test
Complications with phone-administered test
Time Frame: Through study completion, approximately 2 months.
Researchers will recored the % of participants who reported technical or practical difficulties with the phone-administered test including difficulty hearing, understanding the instructions, getting interrupted during the test, or others.
Through study completion, approximately 2 months.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Stanford University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 13, 2019

Primary Completion (Actual)

October 14, 2019

Study Completion (Actual)

October 14, 2019

Study Registration Dates

First Submitted

August 13, 2019

First Submitted That Met QC Criteria

August 14, 2019

First Posted (Actual)

August 15, 2019

Study Record Updates

Last Update Posted (Actual)

October 31, 2019

Last Update Submitted That Met QC Criteria

October 30, 2019

Last Verified

October 1, 2019

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • 51970

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

IPD Plan Description

Please email PI for data if interested.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Testing the Hypnotizability of Healthy Volunteers

Clinical Trials on Hypnotizability testing

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Morocco

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe